[go: up one dir, main page]

TW200801016A - Thienopyridine-2-carboxamide derivatives - Google Patents

Thienopyridine-2-carboxamide derivatives

Info

Publication number
TW200801016A
TW200801016A TW095137329A TW95137329A TW200801016A TW 200801016 A TW200801016 A TW 200801016A TW 095137329 A TW095137329 A TW 095137329A TW 95137329 A TW95137329 A TW 95137329A TW 200801016 A TW200801016 A TW 200801016A
Authority
TW
Taiwan
Prior art keywords
thienopyridine
carboxamide derivatives
compound
pharmaceutically acceptable
group
Prior art date
Application number
TW095137329A
Other languages
Chinese (zh)
Inventor
Satoru Naito
Akira Nakao
Tsuyoshi Shinozuka
Keiji Saito
Kiyoshi Oizumi
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of TW200801016A publication Critical patent/TW200801016A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention relates to a compound of the following formula (I) [wherein, R1 represents a hydrogen atom, an C1-6 alkyl group; R2 represents a substituted cycloamino group] or the pharmaceutically acceptable salt thereof.
TW095137329A 2005-10-12 2006-10-11 Thienopyridine-2-carboxamide derivatives TW200801016A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2005297056 2005-10-12

Publications (1)

Publication Number Publication Date
TW200801016A true TW200801016A (en) 2008-01-01

Family

ID=37942811

Family Applications (1)

Application Number Title Priority Date Filing Date
TW095137329A TW200801016A (en) 2005-10-12 2006-10-11 Thienopyridine-2-carboxamide derivatives

Country Status (2)

Country Link
TW (1) TW200801016A (en)
WO (1) WO2007043581A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009102761A1 (en) 2008-02-12 2009-08-20 Bristol-Myers Squibb Company 1,2,3-triazoles as 11-beta hydroxysteroid dehydrogenase type i inhibitors
CN120858099A (en) * 2023-03-22 2025-10-28 上海齐鲁制药研究中心有限公司 CDK inhibitors

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6964956B2 (en) * 2002-06-06 2005-11-15 Boehringer Ingelheim Pharmaceuticals, Inc. Substituted 3-amino-thieno [2,3-b]pyridine-2-carboxylic acid amide compounds and processes for preparing and their uses
JP2005325099A (en) * 2004-04-12 2005-11-24 Sankyo Co Ltd Thienopyridine derivative

Also Published As

Publication number Publication date
WO2007043581A1 (en) 2007-04-19

Similar Documents

Publication Publication Date Title
WO2008108378A3 (en) Bicyclic oxomorpholine derivative
TN2009000024A1 (en) Prodrug of cinnamide compound
UA105185C2 (en) Pyrrols
IN2014CN00613A (en)
TW200728307A (en) Novel spirochromanone derivatives
WO2008114817A1 (en) Novel adenine compound
AU2008303600A8 (en) 1,1,1-trifluoro-2-hydroxy-3-phenylpropane derivatives
MY148703A (en) Polycyclic cinnamide derivatives
TW200642683A (en) Heterocyclic compound
TNSN08407A1 (en) Organic compounds
TW200626610A (en) Analogs of 17-hydroxywortmannin as PI3K inhibitors
TW200612958A (en) Substituted imidazole derivatives
NZ592497A (en) Derivatives of 1-amino-2-cyclobutylethylboronic acid
IL204621A (en) Bicyclic - gamma - amino acid derivatives, compositions comprising the same and uses thereof
TW200732306A (en) Pyrimidine derivatives
MX2009003739A (en) Hydrobenzamide derivatives as inhibitors of hsp90.
WO2007109578A3 (en) Substituted gamma lactams as prostaglandin ep2 agonists
UA95972C2 (en) Aminopyridine derivatives having aurora a selective inhibitory action
TW200745034A (en) New compounds
TW200738667A (en) Preparation method for dioxan-2-ylalkylcarbamate derivatives and intermediate thereof
MX2010001566A (en) Aminopyrazole amide derivative.
WO2009154754A3 (en) Synthesis of deuterated morpholine derivatives
WO2006113509A3 (en) Quinobenzoxazine analogs and methods of using thereof
MX2009004343A (en) Organic compounds.
NZ596653A (en) Total synthesis of salinosporamide a and analogs thereof